Triple therapy in COPD: only for the right patient
We thank A. Papi and co-workers for their letter on our examination of the recent single inhaler triple therapy trials. Their additional analyses provide further evidence for our interpretation that these trials provide significant opportunities for a precision medicine approach to chronic obstructive pulmonary disease (COPD) treatment [1].
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Suissa, S., Ariel, A. Tags: Original Articles: Correspondence Source Type: research
More News: Chronic Obstructive Pulmonary | Respiratory Medicine